Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The present study is designed to reveal effectiveness of hyaluronidase and dexamethasone on reduction of postoperative edema, pain, trismus, and infection. For this purpose, 60 participants with symmetrical mandibular wisdom teeth enrolled the present study. All measurements and evaluations were performed before and 1, 2, 3, and 7 days later the operation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| hyaluronidase | Experimental |
| |
| hyaluronidase control | No Intervention | ||
| dexamethasone | Experimental |
| |
| dexamethasone control | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hyaluronidase Injection mesomedica | Drug | injection of 150 IU hyaluronidase to perioperative region, submucosally. |
|
| Measure | Description | Time Frame |
|---|---|---|
| evaluation of the increase of edema in postoperative 1. day using a measuring tape in hyaluronidase experimental group | preoperative edema amount was subtracted from edema amount in 1. day in hyaluronidase experimental group | postoperative 1. day |
| evaluation of the increase of edema in postoperative 2. day using a measuring tape in hyaluronidase experimental group | preoperative edema amount was subtracted from edema amount in 2. day in hyaluronidase experimental group | postoperative 2. day |
| evaluation of the increase of edema in postoperative 3. day using a measuring tape in hyaluronidase experimental group | preoperative edema amount was subtracted from edema amount in 3. day in hyaluronidase experimental group | postoperative 3. day |
| evaluation of the increase of edema in postoperative 7. day using a measuring tape in hyaluronidase experimental group | preoperative edema amount was subtracted from edema amount in 7. day in hyaluronidase experimental group | postoperative 7. day |
| evaluation of the increase of edema in postoperative 1. day using a measuring tape in hyaluronidase control group | preoperative edema amount was subtracted from edema amount in 1. day in hyaluronidase control group | postoperative 1. day |
| evaluation of the increase of edema in postoperative 2. day using a measuring tape in hyaluronidase control group | preoperative edema amount was subtracted from edema amount in 2. day in hyaluronidase control group |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Near East University | Nicosia | 99138 | Cyprus | |||
| Hacettepe University |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39215323 | Derived | Koc O, Er N, Karaca C, Bilginaylar K. Comparison of the effects of submucosal hyaluronidase and dexamethasone on postoperative edema, pain, trismus, and infection following impacted third molar surgery. BMC Oral Health. 2024 Aug 30;24(1):1018. doi: 10.1186/s12903-024-04729-1. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004487 | Edema |
| D010146 | Pain |
| D014313 | Trismus |
| D013530 | Surgical Wound Infection |
| D000377 | Agnosia |
| D014946 | Wound Infection |
| ID | Term |
|---|---|
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009461 | Neurologic Manifestations |
| D013035 | Spasm |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dexamethasone dekort | Drug | injection of 8 mg dexamethasone to perioperative region, submucosally. |
|
| postoperative 2. day |
| evaluation of the increase of edema in postoperative 3. day using a measuring tape in hyaluronidase control group | preoperative edema amount was subtracted from edema amount in 3. day in hyaluronidase control group | postoperative 3. day |
| evaluation of the increase of edema in postoperative 7. day using a measuring tape in hyaluronidase control group | preoperative edema amount was subtracted from edema amount in 7. day in hyaluronidase control group | postoperative 7. day |
| evaluation of the increase of edema in postoperative 1. day using a measuring tape in dexamethasone experimental group | preoperative edema amount was subtracted from edema amount in 1. day in dexamethasone experimental group | postoperative 1. day |
| evaluation of the increase of edema in postoperative 2. day using a measuring tape in dexamethasone experimental group | preoperative edema amount was subtracted from edema amount in 2. day in dexamethasone experimental group | postoperative 2. day |
| evaluation of the increase of edema in postoperative 3. day using a measuring tape in dexamethasone experimental group | preoperative edema amount was subtracted from edema amount in 3. day in dexamethasone experimental group | postoperative 3. day |
| evaluation of the increase of edema in postoperative 7. day using a measuring tape in dexamethasone experimental group | preoperative edema amount was subtracted from edema amount in 7. day in dexamethasone experimental group | postoperative 7. day |
| evaluation of the increase of edema in postoperative 1. day using a measuring tape in dexamethasone control group | preoperative edema amount was subtracted from edema amount in 1. day in dexamethasone controlgroup | postoperative 1. day |
| evaluation of the increase of edema in postoperative 2. day using a measuring tape in dexamethasone control group | preoperative edema amount was subtracted from edema amount in 2. day in dexamethasone controlgroup | postoperative 2. day |
| evaluation of the increase of edema in postoperative 3. day using a measuring tape in dexamethasone control group | preoperative edema amount was subtracted from edema amount in 3. day in dexamethasone controlgroup | postoperative 3. day |
| evaluation of the increase of edema in postoperative 7. day using a measuring tape in dexamethasone control group | preoperative edema amount was subtracted from edema amount in 7. day in dexamethasone controlgroup | postoperative 7. day |
| evaluation of the difference in increase amounts of edema between hyaluronidase experimental and hyaluronidase control groups in postoperative 1. day using a measuring tape | edema increase amount of hyaluronidase experimental group was compared with that of hyaluronidase control group in postoperative 1. day | postoperative 1. day |
| evaluation of the difference in increase amounts of edema between hyaluronidase experimental and hyaluronidase control groups in postoperative 2. day using a measuring tape | edema increase amount of hyaluronidase experimental group was compared with that of hyaluronidase control group in postoperative 2. day | postoperative 2. day |
| evaluation of the difference in increase amounts of edema between hyaluronidase experimental and hyaluronidase control groups in postoperative 3. day using a measuring tape | edema increase amount of hyaluronidase experimental group was compared with that of hyaluronidase control group in postoperative 3. day | postoperative 3. day |
| evaluation of the difference in increase amounts of edema between hyaluronidase experimental and hyaluronidase control groups in postoperative 7. day using a measuring tape | edema increase amount of hyaluronidase experimental group was compared with that of hyaluronidase control group in postoperative 7. day | postoperative 7. day |
| evaluation of the difference in increase amounts of edema between dexamethasone experimental and dexamethasone control groups in postoperative 1. day using a measuring tape | edema increase amount of dexamethasone experimental group was compared with that of dexamethasone control group in postoperative 1. day | postoperative 1. day |
| evaluation of the difference in increase amounts of edema between dexamethasone experimental and dexamethasone control groups in postoperative 2. day using a measuring tape | edema increase amount of dexamethasone experimental group was compared with that of dexamethasone control group in postoperative 2. day | postoperative 2. day |
| evaluation of the difference in increase amounts of edema between dexamethasone experimental and dexamethasone control groups in postoperative 3. day using a measuring tape | edema increase amount of dexamethasone experimental group was compared with that of dexamethasone control group in postoperative 3. day | postoperative 3. day |
| evaluation of the difference in increase amounts of edema between dexamethasone experimental and dexamethasone control groups in postoperative 7. day using a measuring tape | edema increase amount of dexamethasone experimental group was compared with that of dexamethasone control group in postoperative 7. day | postoperative 7. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase experimental group in postoperative 1. day | pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 1. day | postoperative 1. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase experimental group in postoperative 2. day | pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 2. day | postoperative 2. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase experimental group in postoperative 3. day | pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 3. day | postoperative 3. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase experimental group in postoperative 4. day | pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 4. day | postoperative 4. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase experimental group in postoperative 5. day | pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 5. day | postoperative 5. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase experimental group in postoperative 6. day | pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 6. day | postoperative 6. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase experimental group in postoperative 7. day | pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 7. day | postoperative 7. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase control group in postoperative 1. day | pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 1. day | postoperative 1. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase control group in postoperative 2. day | pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 2. day | postoperative 2. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase control group in postoperative 3. day | pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 3. day | postoperative 3. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase control group in postoperative 4. day | pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 4. day | postoperative 4. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase control group in postoperative 5. day | pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 5. day | postoperative 5. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase control group in postoperative 6. day | pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 6. day | postoperative 6. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in hyaluronidase control group in postoperative 7. day | pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 7. day | postoperative 7. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone experimental group in postoperative 1. day | pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 1. day | postoperative 1. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone experimental group in postoperative 2. day | pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 2. day | postoperative 2. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone experimental group in postoperative 3. day | pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 3. day | postoperative 3. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone experimental group in postoperative 4. day | pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 4. day | postoperative 4. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone experimental group in postoperative 5. day | pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 5. day | postoperative 5. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone experimental group in postoperative 6. day | pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 6. day | postoperative 6. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone experimental group in postoperative 7. day | pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 7. day | postoperative 7. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone control group in postoperative 1. day | pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 1. day | postoperative 1. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone control group in postoperative 2. day | pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 2. day | postoperative 2. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone control group in postoperative 3. day | pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 3. day | postoperative 3. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone control group in postoperative 4. day | pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 4. day | postoperative 4. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone control group in postoperative 5. day | pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 5. day | postoperative 5. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone control group in postoperative 6. day | pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 6. day | postoperative 6. day |
| evaluation of the pain using visual analog scale (VAS) and daily count of NSAİ drug intake in dexamethasone control group in postoperative 7. day | pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAİ drug intake in postoperative 7. day | postoperative 7. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group preoperatively. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | preoperative |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group in postoperative 1. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 1. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group in postoperative 2. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 2. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group in postoperative 3. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 3. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group in postoperative 7. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 7. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group preoperatively. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | preoperative |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group in postoperative 1. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 1. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group in postoperative 2. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 2. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group in postoperative 3. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 3. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group in postoperative 7. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 7. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group preoperatively. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | preoperative |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group in postoperative 1. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 1. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group in postoperative 2. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 2. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group in postoperative 3. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 3. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group in postoperative 7. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 7. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group preoperatively. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | preoperative |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group in postoperative 1. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 1. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group in postoperative 2. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 2. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group in postoperative 3. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 3. day |
| evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group in postoperative 7. day. | amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler | postoperative 7. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group preoperatively. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | preoperative |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group in postoperative 1. day. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 1. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group in postoperative 2. day. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 2. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group in postoperative 3. day. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 3. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group in postoperative 7. day. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 7. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group preoperatively. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | preoperative |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group in postoperative 1. day. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 1. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group in postoperative 2. day. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 2. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group in postoperative 3. day. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 3. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group in postoperative 7. day. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 7. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group preoperatively. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | preoperative |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group in postoperative 1. day | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 1. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group in postoperative 2. day | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 2. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group in postoperative 3. day | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 3. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group in postoperative 7. day | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 7. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group preoperatively. | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | preoperatively |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group in postoperative 1. day | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 1. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group in postoperative 2. day | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 2. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group in postoperative 3. day | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 3. day |
| evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group in postoperative 7. day | existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. | postoperative 7. day |
| Ankara |
| Sıhhiye |
| 06100 |
| Turkey (Türkiye) |
| D020879 | Neuromuscular Manifestations |
| D009422 | Nervous System Diseases |
| D007239 | Infections |
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |